-
Signature
-
/s/ Chris Utecht, Attorney-in-Fact
-
Issuer symbol
-
WRBY
-
Transactions as of
-
11 Sep 2025
-
Net transactions value
-
-$1,129,831
-
Form type
-
4
-
Filing time
-
15 Sep 2025, 17:17:50 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Gilboa David Abraham |
Co-Chief Executive Officer, Director |
C/O WARBY PARKER INC.,, 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK |
/s/ Chris Utecht, Attorney-in-Fact |
15 Sep 2025 |
0001883353 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
WRBY |
Class A Common Stock |
Conversion of derivative security |
$0 |
+41,040 |
+125% |
$0.000000 |
73,901 |
11 Sep 2025 |
Direct |
|
| transaction |
WRBY |
Class A Common Stock |
Sale |
$1,129,831 |
-41,040 |
-56% |
$27.53 |
32,861 |
11 Sep 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
WRBY |
Class B Common Stock |
Conversion of derivative security |
$0 |
-41,040 |
-0.77% |
$0.000000 |
5,272,880 |
11 Sep 2025 |
Class A Common Stock |
41,040 |
|
Direct |
F3, F4 |
| holding |
WRBY |
Class B Common Stock |
|
|
|
|
|
1,656,770 |
11 Sep 2025 |
Class A Common Stock |
1,656,770 |
|
By David A. Gilboa 2012 Family Trust |
F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: